Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine
Our knowledge of pluripotent stem cell (PSC) biology has advanced to the point where we
now can generate most cells of the human body in the laboratory. PSC-derived …
now can generate most cells of the human body in the laboratory. PSC-derived …
Current challenges of iPSC-based disease modeling and therapeutic implications
MX Doss, A Sachinidis - Cells, 2019 - mdpi.com
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement
therapy approach have proven to be very powerful and instrumental in biomedical research …
therapy approach have proven to be very powerful and instrumental in biomedical research …
A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes
RE Ahmed, T Anzai, N Chanthra… - Frontiers in cell and …, 2020 - frontiersin.org
Cardiovascular diseases are the leading cause of death worldwide. Therefore, the discovery
of induced pluripotent stem cells (iPSCs) and the subsequent generation of human induced …
of induced pluripotent stem cells (iPSCs) and the subsequent generation of human induced …
Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1α and LDHA
D Hu, A Linders, A Yamak, C Correia… - Circulation …, 2018 - Am Heart Assoc
Rationale: Human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are a readily
available, robustly reproducible, and physiologically appropriate human cell source for …
available, robustly reproducible, and physiologically appropriate human cell source for …
[HTML][HTML] PPARdelta activation induces metabolic and contractile maturation of human pluripotent stem cell-derived cardiomyocytes
NM Wickramasinghe, D Sachs, B Shewale… - Cell Stem Cell, 2022 - cell.com
Pluripotent stem-cell-derived cardiomyocytes (PSC-CMs) provide an unprecedented
opportunity to study human heart development and disease, but they are functionally and …
opportunity to study human heart development and disease, but they are functionally and …
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering
MF Tenreiro, AF Louro, PM Alves… - NPJ Regenerative …, 2021 - nature.com
The adult heart is a vital and highly specialized organ of the human body, with limited
capability of self-repair and regeneration in case of injury or disease. Engineering …
capability of self-repair and regeneration in case of injury or disease. Engineering …
Generation of human iPSCs derived heart organoids structurally and functionally similar to heart
SG Lee, YJ Kim, MY Son, MS Oh, J Kim, B Ryu… - Biomaterials, 2022 - Elsevier
Currently, due to the increasing demand for 3D culture, various organoids that mimic organs
are being actively studied. Despite active reports, information on heart organoids (HOs) …
are being actively studied. Despite active reports, information on heart organoids (HOs) …
3D cardiac cell culture: a critical review of current technologies and applications
C Zuppinger - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
Three-dimensional (3D) cell culture is often mentioned in the context of regenerative
medicine, for example, for the replacement of ischemic myocardium with tissue-engineered …
medicine, for example, for the replacement of ischemic myocardium with tissue-engineered …
Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research
K Andrysiak, J Stępniewski, J Dulak - Pflügers Archiv-European Journal of …, 2021 - Springer
Abstract Development of new drugs is of high interest for the field of cardiac and
cardiovascular diseases, which are a dominant cause of death worldwide. Before being …
cardiovascular diseases, which are a dominant cause of death worldwide. Before being …
[HTML][HTML] Current methods for the maturation of induced pluripotent stem cell-derived cardiomyocytes
P Machiraju, SC Greenway - World journal of stem cells, 2019 - ncbi.nlm.nih.gov
Induced pluripotent stem cells (iPSCs) were first generated by Yamanaka and colleagues
over a decade ago. Since then, iPSCs have been successfully differentiated into many …
over a decade ago. Since then, iPSCs have been successfully differentiated into many …